Predicting the Presence and Side of Extracapsular Extension: A Nomogram for Staging Prostate Cancer
- 1 May 2004
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 171 (5) , 1844-1849
- https://doi.org/10.1097/01.ju.0000121693.05077.3d
Abstract
We developed a model to predict the side specific probability of extracapsular extension (ECE) in radical prostatectomy (RP) specimens based on the clinical features of the cancer. We studied 763 patients with clinical stage T1c-T3 prostate cancer who were diagnosed by systematic needle biopsy and subsequently treated with RP. Candidate predictor variables associated with ECE were clinical T stage, the highest Gleason sum in any core, percent positive cores, percent cancer in the cores from each side and serum prostate specific antigen (PSA). Receiver operating characteristic (ROC) analyses were performed to assess the predictive value of each variable alone and in combination. We constructed and internally validated nomograms to predict the side specific probability of ECE based on logistic regression analysis. Overall 30% of the patients and 17% of 1,526 prostate lobes (left or right) had ECE. The areas under the ROC curves (AUC) of the standard features in predicting side specific probability of ECE were 0.627 for PSA, 0.695 for clinical T stage on each side and 0.727 for Gleason sum on each side. When these features were combined predictive accuracy increased to 0.788. The highest value (0.806) was achieved by adding the percent positive cores and the percent cancer in the biopsy specimen to the standard features. The resulting nomograms were internally validated and had excellent calibration and discrimination accuracy. Standard clinical features of prostate cancer in each lobe—PSA, palpable induration and biopsy Gleason sum—can be used to predict the side specific probability of ECE in RP specimens. The predictive accuracy is increased by adding information from systematic biopsy results. The predictive nomograms are sufficiently accurate for use in clinical practice in decisions such as wide versus close dissection of the cavernous nerves from the prostate.Keywords
This publication has 19 references indexed in Scilit:
- Sextant Prostate Biopsies Predict Side and Sextant Site of Extracapsular Extension of Prostate CancerJournal of Urology, 2002
- Percent Of Cancer in the Biopsy Set Predicts Pathological Findings After ProstatectomyJournal of Urology, 2002
- Contemporary update of prostate cancer staging nomograms (Partin Tables) for the new millenniumUrology, 2001
- A VALIDATED STRATEGY FOR SIDE SPECIFIC PREDICTION OF ORGAN CONFINED PROSTATE CANCER: A TOOL TO SELECT FOR NERVE SPARING RADICAL PROSTATECTOMYJournal of Urology, 2001
- THE EXTENT OF BIOPSY INVOLVEMENT AS AN INDEPENDENT PREDICTOR OF EXTRAPROSTATIC EXTENSION AND SURGICAL MARGIN STATUS IN LOW RISK PROSTATE CANCER: : IMPLICATIONS FOR TREATMENT SELECTIONJournal of Urology, 2000
- FACTORS PREDICTING RECOVERY OF ERECTIONS AFTER RADICAL PROSTATECTOMYJournal of Urology, 2000
- THE PERCENT OF CORES POSITIVE FOR CANCER IN PROSTATE NEEDLE BIOPSY SPECIMENS IS STRONGLY PREDICTIVE OF TUMOR STAGE AND VOLUME AT RADICAL PROSTATECTOMYJournal of Urology, 2000
- DOES SITE SPECIFIC LABELING OF SEXTANT BIOPSY CORES PREDICT THE SITE OF EXTRACAPSULAR EXTENSION IN RADICAL PROSTATECTOMY SURGICAL SPECIMEN?Journal of Urology, 1999
- Systematic sextant biopsies in the prediction of extracapsular extension at radical prostatectomyUrology, 1997
- Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional updatePublished by American Medical Association (AMA) ,1997